[EN] NAPHTHOL, QUINOLINE AND ISOQUINOLINE-DERIVATIVES AS MODULATORS OF VANILLOID VR1 RECEPTOR<br/>[FR] MODULATEURS UREIQUES DU RECEPTEUR VANILLOIDE VR1 DERIVES DU NAPHTOL, DE LA QUINOLINE ET DE L'ISOQUINOLINE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2004007459A3
公开(公告)日:2004-03-18
US7183411B2
申请人:——
公开号:US7183411B2
公开(公告)日:2007-02-27
Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
申请人:——
公开号:US20040157865A1
公开(公告)日:2004-08-12
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to naphthol, quinoline and isoquinoline-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.